| 标题 |
Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:European Heart Journal 作者:Pierre Théroux; Paul W. Armstrong; Kenneth W. Mahaffey; Judith S. Hochman; Kevin J. Malloy; et al 出版日期:2005-05-05 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)